NetworkNewsBreaks – CURE Pharmaceutical (CURR) Appoints Canopy Rivers’ (TSX: RIV) (OTC: CNPOF) Chairman, John K. Bell, to Board of Directors

December 12, 2019 12:52:53

CURE Pharmaceutical (OTCQB: CURR), an innovative drug delivery and development company, recently announced the appointment of John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40 years of experience to Cure Pharmaceutical, most recently serving as chairman of the Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) board of directors. “John’s unparalleled depth and breadth of expertise makes him an invaluable asset to our growth strategy,” CURE Pharmaceutical CEO Rob Davidson said in the news release. “His impressive array of experience supports every aspect of our business, including pharmaceutical, manufacturing, financial and cannabis.”

To view the full press release, visit

About CURE Pharmaceutical

CURE Pharmaceutical(R) is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has a cGMP manufacturing facility and is a pioneering developer and manufacturer of CUREform(TM), a patented and proprietary oral delivery platform that includes CUREfilm(R), one of the most advanced oral thin films on the market today and CUREpods(TM), a novel chewable delivery system. CUREform’s combined technologies provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients. CURE partners with biotech, pharmaceutical and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel, and other markets. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced. For more information about CURE Pharmaceutical, please visit its website at

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office

NetworkNewsWire is part of the InvestorBrandNetwork.